Skip to main content
. 2021 Feb 13;11(2):109. doi: 10.3390/metabo11020109

Table 2.

Metabolite levels significantly different between control and treated BT257 tumors at early (D7 ± 2) and late (D15 ± 1) time points.

D7 ± 2
Metabolite Cramer-Rao Lower Bounds (%) Concentration (AU)
Control AG-881 BAY-1436032 Control AG-881 BAY-1436032
2HG 6 7 5 8.63 ± 0.16 5.57 ± 0.13 6.89 ± 0.13
GSH 6 6 5 2.19 ± 0.04 2.34 ± 0.05 2.53 ± 0.05
NAA 4 4 3 8.54 ± 0.10 11.38 ± 0.10 13.44 ± 0.11
Lac 14 8 6 5.73 ± 0.22 4.48 ± 0.10 4.29 ± 0.11
mI 4 3 2 19.83 ± 0.14 15.27 ± 0.12 20.38 ± 0.13
Asp 22 28 7 6.30 ± 0.19 2.26 ± 0.13 7.75 ± 0.23
Tau 5 3 3 10.74 ± 0.13 14.16 ± 0.16 10.42 ± 0.13
GABA 5 12 4 12.64 ± 0.17 6.62 ± 0.14 13.28 ± 0.19
Ala 22 10 10 0.98 ± 0.05 1.66 ± 0.07 -
Gln 6 5 5 4.93 ± 0.08 4.55 ± 0.09 4.48 ± 0.08
Glu 7 4 4 7.59 ± 0.14 11.10 ± 0.14 11.22 ± 0.16
Gly 5 4 4 27.39 ± 0.35 21.03 ± 0.19 16.23 ± 0.15
sI 14 8 13 0.46 ± 0.02 0.66 ± 0.02 0.88 ± 0.03
tCho 1 1 1 12.70 ± 0.04 8.70 ± 0.04 9.31 ± 0.04
tCr 4 2 2 7.87 ± 0.06 12.13 ± 0.09 8.75 ± 0.07
GLX 5 4 3 13.19 ± 0.18 15.21 ± 0.20 16.39 ± 0.19
D15 ± 1
2HG 4 7 4 14.79 ± 0.20 4.73 ± 0.17 7.42 ± 0.17
GSH 11 7 4 3.41 ± 0.06 2.20 ± 0.07 1.89 ± 0.04
NAA 4 4 4 11.45 ± 0.10 - 8.73 ± 0.08
Lac 8 13 10 7.28 ± 0.19 5.94 ± 0.38 3.18 ± 0.17
mI 3 2 2 19.45 ± 0.11 22.92 ± 0.25 22.49 ± 0.17
Asp 9 10 6 8.44 ± 0.31 4.75 ± 0.24 6.49 ± 0.18
Tau 4 5 4 11.04 ± 0.12 15.38 ± 0.38 11.68 ± 0.17
GABA 4 6 5 20.74 ± 0.18 13.82 ± 0.37 8.48 ± 0.14
Ala 10 11 15 2.29 ± 0.06 - 1.00 ± 0.03
Gln 7 6 6 5.47 ± 0.10 3.90 ± 0.12 2.48 ± 0.07
Glu 5 7 4 7.12 ± 0.13 9.89 ± 0.31 10.83 ± 0.15
Gly 4 6 4 19.87 ± 0.15 13.32 ± 0.38 19.19 ± 0.17
sI 13 14 11 0.57 ± 0.03 0.81 ± 0.06 0.34 ± 0.02
tCho 1 1 1 12.37 ± 0.05 10.60 ± 0.06 11.45 ± 0.06
tCr 3 3 3 7.89 ± 0.06 10.79 ± 0.16 13.31 ± 0.11
GLX 4 5 4 12.03 ± 0.18 13.90 ± 0.34 14.91 ± 0.19